文献速递妇科

微卫星稳定型子宫内膜样癌微创术后生存分析

Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data.
PubMed 文献 · Gynecol Oncol · 2020-05-04

基于TCGA数据的回顾性研究纳入519例子宫内膜癌患者,比较开腹与微创手术的生存结局。微创手术组无复发生存期显著缩短(p=0.005),亚组分析显示该影响仅见于微卫星稳定型子宫内膜样癌患者,多因素分析提示微创手术是全人群(HR=2.038,95%CI 1.111-3.741,p=0.02)及MSS患者(HR=2.449,95%CI 1.064-5.639,p=0.04)无复发生存期缩短的独立危险因素。

要点

  • 微创手术与MSS子宫内膜样癌患者更快的复发相关
  • 微创手术是全人群及MSS患者RFS缩短的独立危险因素
  • 建议进行微卫星检测以指导子宫内膜癌手术方式选择

核心结论

  • 微创手术与微卫星稳定型子宫内膜样癌患者更快的复发相关,提示需微卫星检测指导手术决策。

研究设计与样本

  • 基于TCGA数据的回顾性研究,纳入519例符合条件的子宫内膜癌患者,按组织学和微卫星状态分为四个亚组。

主要发现

  • 全组中318例(61.3%)接受开腹手术,201例(38.7%)接受微创手术。
  • 两组总生存相似(p=0.33),但微创手术组无复发生存期显著缩短(p=0.005)。
  • 亚组分析显示手术方式对生存的影响仅见于微卫星稳定型子宫内膜样癌患者。
  • 多因素分析显示微创手术是全人群RFS缩短的独立危险因素(HR=2.038,95%CI 1.111-3.741,p=0.02)。
  • 微创手术也是MSS患者RFS缩短的独立危险因素(HR=2.449,95%CI 1.064-5.639,p=0.04)。

临床怎么用

  • 对子宫内膜癌患者,尤其是子宫内膜样癌,应考虑微卫星状态检测以辅助选择开腹或微创手术。
  • MSS子宫内膜样癌患者选择微创手术时需警惕复发风险,加强术后随访。

局限性

  • 本研究为基于TCGA数据的回顾性研究,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to investigate the survival impact of minimally invasive surgery on endometrial cancer (EC) patients with different histology and microsatellite status. METHODS: This is a retrospective study based on the Cancer Genome Atlas (TCGA) data. 519 eligible EC patients were divided into four subgroups according to histology and microsatellite status. Kaplan-Meier survival analyses were conducted in all patients and four subgroups to compare the survival outcome after two surgeries (open vs. minimally invasive). Propensity score matching and propensity score covariate adjustment models were used to control confounders. To establish survival prediction models for EC patients, multivariate stepwise Cox regressions were conducted. RESULTS: Among the eligible patients, 318 (61.3%) received open surgery and 201 (38.7%) received minimally invasive surgery. Overall survival was similar between the two groups (p = 0.33), but the latter showed significantly shorter recurrence-free survival (RFS) (p = 0.005). Subgroup analyses revealed the survival influence of surgical approach was only significant in microsatellite-stable (MSS) endometrioid EC patients. These results were verified by Kaplan-Meier survival analyses after propensity score matching and propensity score covariate adjustment models. Finally, the survival influence of multiple clinicopathological factors was analyzed. After stepwise Cox regressions, minimally invasive surgery was found to be independent risk factor for shorter RFS of all patients (hazard ratio [HR] = 2.038, 95% confidence interval [CI] 1.111-3.741, p = 0.02) and MSS patients (HR = 2.449, 95% CI 1.064-5.639, p = 0.04). CONCLUSIONS: Minimally invasive surgery is associated with more rapid recurrence in MSS endometrioid EC patients, thus indicating the necessity of microsatellite testing for guiding EC surgery.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Dai Y, Wang Z, Wang J, et al. Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data. Gynecol Oncol. 2020. PMID: 32376044. doi:10.1016/j.ygyno.2020.04.684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。